KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Tax Provisions (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Tax Provisions readings, the most recent being -$643000.0 for Q4 2025.

  • On a quarterly basis, Tax Provisions fell 97.85% to -$643000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$837000.0, a 74.74% decrease, with the full-year FY2025 number at -$837000.0, down 74.74% from a year prior.
  • Tax Provisions hit -$643000.0 in Q4 2025 for Ginkgo Bioworks Holdings, down from $1000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $190000.0 in Q2 2024 to a low of -$14.8 million in Q4 2022.
  • Median Tax Provisions over the past 5 years was -$171500.0 (2021), compared with a mean of -$894700.0.
  • Biggest five-year swings in Tax Provisions: plummeted 3550.0% in 2021 and later surged 248.89% in 2023.
  • Ginkgo Bioworks Holdings' Tax Provisions stood at -$683000.0 in 2021, then tumbled by 2062.52% to -$14.8 million in 2022, then skyrocketed by 98.66% to -$198000.0 in 2023, then crashed by 64.14% to -$325000.0 in 2024, then plummeted by 97.85% to -$643000.0 in 2025.
  • The last three reported values for Tax Provisions were -$643000.0 (Q4 2025), $1000.0 (Q3 2025), and -$283000.0 (Q2 2025) per Business Quant data.